Previous research has shown that knockdown of CNN3 inhibits extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 phosphorylation, reducing osteosarcoma cell activity and proliferation via the mitogen-activated protein kinase (MAPK) signaling pathway. Here, CNN3 is linked to osteosarcoma.